Unlocking the potential of in vivo cellular reprogramming
MISSSION

Our patented platform overcomes the significant challenges in cellular reprogramming, such as the safety risks of viral vectors and the inefficiencies of non-viral methods.

Utilizing human proteins and natural cellular communication, we offer a safer, precise, and more effective approach to cell engineering within the body.

We are setting a new standard in cellular therapy and regenerative medicine.

SCIENCE
In-Vivo
‍Cellular
Reprogramming
At DNAmic, we recognize the critical challenges currently impeding progress in cellular reprogramming — the toxicity, inefficiency, and potential risks associated with viral vectors, and the limited delivery capabilities and reduced efficiencies of non-viral systems. Our human-based engineering platform represents a pivotal leap in in-vivo cell engineering and reprogramming, designed to transcend these limitations.
Explore
JOIN US

Balancing ambition with openness

We excel in cutting-edge cellular engineering and regenerative medicine, always eager to engage, learn, and grow with fellow pioneers in the biology of cellular rejuvenation.

“ Rather than attempting to do everything on our own, we prefer reaching far and aiming high through collaboration with the best minds. ”

Alfonso Fiz

CEO and CO-Founder DNAmic

Contact
@ 2024 DNAmic BioSystems